Literature DB >> 34111582

Negative SARS-cov-2 antibodies, T-cell response and virus neutralisation following full vaccination in a renal transplant recipient - A call for vigilance.

Rune M Petersen1, Ditte S Tornby2, Claus Bistrup3, Isik S Johansen4, Thomas E Andersen1, Ulrik S Justesen5.   

Abstract

This letter concerns the absence of an immunological response in a renal transplant recipient on immunosuppressive therapy after a full vaccination against SARS-CoV-2 and the need to be vigilant. We find it very important to report this to the scientific community, so that transplant patients can be monitored, protected and helped to stimulate further immunity.
Copyright © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody; Organ transplantation; Renaltransplantation; SARS-CoV-2; Vaccine

Year:  2021        PMID: 34111582     DOI: 10.1016/j.cmi.2021.05.042

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  2 in total

1.  A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort.

Authors:  Pablo Barreiro; Juan Carlos Sanz; Jesús San Román; Marta Pérez-Abeledo; Mar Carretero; Gregoria Megías; José Manuel Viñuela-Prieto; Belén Ramos; Jesús Canora; Francisco Javier Martínez-Peromingo; Raquel Barba; Antonio Zapatero; Francisco Javier Candel
Journal:  J Clin Microbiol       Date:  2022-01-12       Impact factor: 5.948

2.  Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components.

Authors:  Rosalia Busà; Maria Concetta Sorrentino; Giovanna Russelli; Giandomenico Amico; Vitale Miceli; Monica Miele; Mariangela Di Bella; Francesca Timoneri; Alessia Gallo; Giovanni Zito; Daniele Di Carlo; Pier Giulio Conaldi; Matteo Bulati
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.